Cornerstone Planning Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.4K | Sell |
708
-134
| -16% | -$6.33K | 0.01% | 307 |
|
|
2025
Q1 | $51.6K | Buy |
842
+533
| +172% | +$32.7K | 0.01% | 233 |
|
|
2024
Q4 | $27K | Sell |
309
-11
| -3% | -$963 | 0.01% | 266 |
|
|
2024
Q3 | $35.8K | Sell |
320
-14
| -4% | -$1.57K | 0.01% | 228 |
|
|
2024
Q2 | $42.1K | Sell |
334
-22
| -6% | -$2.77K | 0.01% | 226 |
|
|
2024
Q1 | $43.8K | Sell |
356
-6
| -2% | -$738 | 0.01% | 186 |
|
|
2023
Q4 | $37.4K | Sell |
362
-16
| -4% | -$1.66K | 0.01% | 220 |
|
|
2023
Q3 | $34.4K | Buy |
378
+24
| +7% | +$2.18K | 0.01% | 230 |
|
|
2023
Q2 | $28.6K | Buy |
+354
| New | +$28.6K | 0.01% | 346 |
|
|
2022
Q4 | $27.6K | Buy |
+392
| New | +$27.6K | 0.01% | 364 |
|